Ian Karp | VP, Investor & Public Relations |
Michael Kauffman | Co-Founder, CEO & Director |
John Demaree | Chief Commercial Officer |
Michael Mason | SVP, CFO & Treasurer |
Sharon Shacham | Co-Founder, President, Chief Scientific Officer & Co-Chairman, Scientific Advisory Board |
Christopher Primiano | EVP, Chief Business Officer, General Counsel & Secretary |
Maurice Raycroft | Jefferies |
Michael Ulz | Robert W. Baird & Co. |
Peter Lawson | Barclays Bank |
Eric Joseph | JPMorgan Chase & Co. |
Jonathan Chang | SVB Leerink |
Brian Abrahams | RBC Capital Markets |
David Lebowitz | Morgan Stanley |
Edward White | H.C. Wainwright & Co. |
Good morning. My name is Debbie, and I will be your conference operator today. I will -- at this time, I would like to welcome everyone to Karyopharm Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the call over to Mr.